Invitae Corporation
NVTA
Hisse Senetlerindeki Sıralama
#35702
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Hisse Fiyatı
$0.016
Son senkronizasyon: 2024-03-11
Piyasa Değeri
$3.27M
Değişim (1 gün)
-5.33%
Değişim (1 yıl)
5,233.33%
Ülke
US
Ticaret Invitae Corporation (NVTA)
Kategori
Healthcare
Invitae Corporation (NVTA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.00 - 2024-08-01
Gün sonu en düşük fiyat: $19.17 - 2015-02-01
Gün sonu en düşük fiyat: $19.17 - 2015-02-01
Invitae Corporation için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
